130 related articles for article (PubMed ID: 29970523)
1.
Bourichi S; Misbahi H; Rodi YK; Chahdi FO; Essassi EM; Szabó S; Szalontai B; Gajdács M; Molnár J; Spengler G
Anticancer Res; 2018 Jul; 38(7):3999-4003. PubMed ID: 29970523
[TBL] [Abstract][Full Text] [Related]
2. Search for ABCB1 Modulators Among 2-Amine-5-Arylideneimidazolones as a New Perspective to Overcome Cancer Multidrug Resistance.
Kaczor A; Nové M; Kincses A; Spengler G; Szymańska E; Latacz G; Handzlik J
Molecules; 2020 May; 25(9):. PubMed ID: 32403277
[TBL] [Abstract][Full Text] [Related]
3. Multidrug resistance reversing activity of newly developed phenothiazines on P-glycoprotein (ABCB1)-related resistance of mouse T-lymphoma cells.
Spengler G; Takács D; Horváth A; Riedl Z; Hajós G; Amaral L; Molnár J
Anticancer Res; 2014 Apr; 34(4):1737-41. PubMed ID: 24692704
[TBL] [Abstract][Full Text] [Related]
4. Reversal of ABCB1-related Multidrug Resistance of Colonic Adenocarcinoma Cells by Phenothiazines.
Takács D; Csonka Á; Horváth Á; Windt T; Gajdács M; Riedl Z; Hajós G; Amaral L; Molnár J; Spengler G
Anticancer Res; 2015 Jun; 35(6):3245-51. PubMed ID: 26026084
[TBL] [Abstract][Full Text] [Related]
5. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
[TBL] [Abstract][Full Text] [Related]
6. Benzoxazole-based Zn(II) and Cu(II) Complexes Overcome Multidrug-resistance in Cancer.
Spengler G; Kincses A; Rácz B; Varga B; Watanabe G; Saijo R; Sekiya H; Tamai E; Maki J; Molnár J; Kawase M
Anticancer Res; 2018 Nov; 38(11):6181-6187. PubMed ID: 30396935
[TBL] [Abstract][Full Text] [Related]
7. Computer-Aided Search for 5-Arylideneimidazolone Anticancer Agents Able To Overcome ABCB1-Based Multidrug Resistance.
Kaczor A; Szemerédi N; Kucwaj-Brysz K; Dąbrowska M; Starek M; Latacz G; Spengler G; Handzlik J
ChemMedChem; 2021 Aug; 16(15):2386-2401. PubMed ID: 33929088
[TBL] [Abstract][Full Text] [Related]
8. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic and multidrug resistance reversal activities of novel 1,4-dihydropyridines against human cancer cells.
Shekari F; Sadeghpour H; Javidnia K; Saso L; Nazari F; Firuzi O; Miri R
Eur J Pharmacol; 2015 Jan; 746():233-44. PubMed ID: 25445037
[TBL] [Abstract][Full Text] [Related]
10. Effect of thioridazine stereoisomers on the drug accumulation of mouse lymphoma and human prostate cancer cell lines in vitro.
Csonka Á; Spengler G; Martins A; Ocsovszki I; Christensen JB; Hendricks O; Kristiansen JE; Amaral L; Molnar J
In Vivo; 2013; 27(6):815-20. PubMed ID: 24292587
[TBL] [Abstract][Full Text] [Related]
11. CEP-33779 antagonizes ATP-binding cassette subfamily B member 1 mediated multidrug resistance by inhibiting its transport function.
Tang SJ; Chen LK; Wang F; Zhang YK; Huang ZC; To KK; Wang XK; Talele TT; Chen ZS; Chen WQ; Fu LW
Biochem Pharmacol; 2014 Sep; 91(2):144-56. PubMed ID: 25058526
[TBL] [Abstract][Full Text] [Related]
12. The 5-aromatic hydantoin-3-acetate derivatives as inhibitors of the tumour multidrug resistance efflux pump P-glycoprotein (ABCB1): Synthesis, crystallographic and biological studies.
Żesławska E; Kincses A; Spengler G; Nitek W; Wyrzuc K; Kieć-Kononowicz K; Handzlik J
Bioorg Med Chem; 2016 Jun; 24(12):2815-22. PubMed ID: 27160056
[TBL] [Abstract][Full Text] [Related]
13. 4,5-Di-substituted benzyl-imidazol-2-substituted amines as the structure template for the design and synthesis of reversal agents against P-gp-mediated multidrug resistance breast cancer cells.
Zhang N; Zhang Z; Wong IL; Wan S; Chow LM; Jiang T
Eur J Med Chem; 2014 Aug; 83():74-83. PubMed ID: 24952376
[TBL] [Abstract][Full Text] [Related]
14. Epoxylathyrol Derivatives: Modulation of ABCB1-Mediated Multidrug Resistance in Human Colon Adenocarcinoma and Mouse T-Lymphoma Cells.
Matos AM; Reis M; Duarte N; Spengler G; Molnár J; Ferreira MJ
J Nat Prod; 2015 Sep; 78(9):2215-28. PubMed ID: 26331763
[TBL] [Abstract][Full Text] [Related]
15. In vitro cytotoxic activity of novel protoflavone analogs - selectivity towards a multidrug resistant cancer cell line.
Danko B; Martins A; Chuang DW; Wang HC; Amaral L; Molnár J; Chang FR; Wu YC; Hunyadi A
Anticancer Res; 2012 Jul; 32(7):2863-9. PubMed ID: 22753749
[TBL] [Abstract][Full Text] [Related]
16. Enhancing chemosensitivity in ABCB1- and ABCG2-overexpressing cells and cancer stem-like cells by an Aurora kinase inhibitor CCT129202.
Cheng C; Liu ZG; Zhang H; Xie JD; Chen XG; Zhao XQ; Wang F; Liang YJ; Chen LK; Singh S; Chen JJ; Talele TT; Chen ZS; Zhong FT; Fu LW
Mol Pharm; 2012 Jul; 9(7):1971-82. PubMed ID: 22632055
[TBL] [Abstract][Full Text] [Related]
17. New Chalcone Derivative Inhibits ABCB1 in Multidrug Resistant T-cell Lymphoma and Colon Adenocarcinoma Cells.
Čižmáriková M; Takáč P; Spengler G; Kincses A; Nové M; Vilková M; Mojžiš J
Anticancer Res; 2019 Dec; 39(12):6499-6505. PubMed ID: 31810914
[TBL] [Abstract][Full Text] [Related]
18. Identification of selenocompounds with promising properties to reverse cancer multidrug resistance.
Domínguez-Álvarez E; Gajdács M; Spengler G; Palop JA; Marć MA; Kieć-Kononowicz K; Amaral L; Molnár J; Jacob C; Handzlik J; Sanmartín C
Bioorg Med Chem Lett; 2016 Jun; 26(12):2821-2824. PubMed ID: 27156771
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of new potent N,N-bis(arylalkyl)piperazine derivatives as multidrug resistance (MDR) reversing agents.
Dei S; Coronnello M; Bartolucci G; Manetti D; Romanelli MN; Udomtanakunchai C; Salerno M; Teodori E
Eur J Med Chem; 2018 Mar; 147():7-20. PubMed ID: 29421572
[TBL] [Abstract][Full Text] [Related]
20. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
